This webinar aims to discuss the current knowledge on autoimmune pulmonary alveolar proteinosis (PAP) and interstitial pneumonia with autoimmune features (IPAF) and highlight the need for a guideline document regarding the connective tissue disease associated interstitial lung disease (CTD-ILD) from the pneumologist and rheumatologist point of view.
Educational aims:
- Overview of the research entity IPAF, what is the current knowledge regarding the diagnosis, treatment and prognosis. Discussion on whether there is ground to switch the definition of IPAF from research to clinical entity.
- The diagnosis and treatment of CTD-ILDs poses significant difficulties in the everyday clinical practice of both pneumologists and rheumatologists. The need for a guideline document will be discussed by physicians from both specialties.
Topics
- IPAF: Is it a clinical diagnosis? – George Margaritopoulos
- Guidelines in CTD-ILD:
– The pulmonologist’s view – Vincent Cottin
– The Rheumatologist’s view – Britta Mauer
Target audience
- Pulmonologists
- Rheumatologists
Learning outcomes
The participants of the webinar will get information about whether the research entity of IPAF could be formally established as clinical entity and what will be the implications of this switch in the everyday clinical practice. Finally, the need of a formal guideline document on the diagnosis and management of CTD-ILDs will be discussed by the specialties involved in the management of these patients.
Format
The webinar will include three lectures, followed by a final round table discussion based on audience Q&A.
CME credit
An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.
What is a webinar?
A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
Login guidelines
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
- Check Central European Time.
- To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.
Diseases/methods:
- Interstitial lung diseases
Target audience
- Pulmonologists
- Rheumatologists